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ABSTRACT
Typical medical diagnosis applications of neural networks
for prediction and classification require training data
(observations) that include the "correct" category for a
number ofpatient records. In this paper, we borrow a
technique from control systems applications of neural
networks. Optimal control parameters of a system are
typically not known. Instead, we only know the effect on a
remote system. The correct control action drives the
remote system optimally. The learning technique requires
two networks: one to model the system to be controlled
(here, the patient), and one to optimize the treatment (here,
the treating physician). The concept was tested with
artificially generated noisy data, and gives promising
results.
INTRODUCTION
The task of medical treatment is to optimize a mapping
from the space of patient states (patient measures,
including biometric data and symptoms) to the space of
treatments (here, dosages). Standard statistical approaches,
including supervised learning with neural networks,
require "training data" consisting of many input-output
pairs (here, symptom-treatment pairs). However, in many
cases, these kind of data are unavailable since the optimal
treatment is not known; rather, the dosage is prescribed
based on broad guidelines, the weight of the patient. In
cases with multiple symptoms and multiple medications,
prescriptive tools available to the physician are primitive at
best.
An approach to "distal leaming" (Williams, 1986; Munro,
1987; Jordan and Rumelhart, 1992) specifies a framework
for training a network to perform an action (A) in response
to a situation (S), where there are no training data
indicating "correct" S-A pairs. Instead, it is assumed that
"indirect" feedback data are available that express some
consequence (C) of certain situation-action combinations.
This approach has proven valuable in understanding motor
control in humans and in artificial systems (Jordan, 1996).
THE MODEL
Two networks, a patient model (PM) and a treatment
network (TN), are trained using backpropagation on
artificial data that mimics hypothetical patient records (see
Figure 1). Each record includes age, gender, an initial
symptomatic measure (this could correspond to blood
pressure, tumor size, etc.), dosage values of two
medications, and a second measure (following treatment).
Training occurs in two stages: First, the patient model is
trained to predict the new symptom values from patient
data (including initial symptoms) and treatment (dosages).
In the second stage, the weight parameters in the TN are
trained to optimize the output of the patient model
according to backpropagated gradients; while the treatment
network is trained, the weights in the PM are held fixed.
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Figure 1. The Distal Learning System. Shaded
rectangles represent networks and white rectangles
represent fields from the observed data set. The
Patient Model (PM) is trained to predict followup
symptoms after treatment for patient records in the
training set. The parameters in the PM are then held
fixed (solid arrows) while the Treatment Network
(TN) parameters (dashed arrow) are trained to
optimize the predicted symptoms.
GENERATION OF ARTIFICIAL DATA
Each data set consisted of 6000 artificially generated
patient records. An age value for data item a, ya, is
drawn from the normal distribution with mean 50 years
and standard deviation 8 years. Gender (ga) is coded by
choosing 0 or 1 randomly with probability 0.5. Doses of
the two medications (dl and d2) were randomly drawn
from the uniform distribution [0.2, 0.8]. It is assumed that
the optimal dose of medication 1 is strictly a function of
age (dfPt= age/100), and that the optimal value of
medication 2 is strictly a function of gender: For females,
d2pt=0.3, and for males, d2Pt=0.7. The effect of the
medications falls off according to a Gaussian function
from the ideal points. This function is then multiplied by
the initial symptom value Si to give a followup value
Sf (see equation below). A random number p(n),
uniformly drawn from the interval [-n,n], is added to each
target value.
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It is assumed here that it is in the interest of patients to
minimize sf. The framework could easily be extended to
multiple symptoms, where each one has a different optimal
value. The data set included 6000 independently generated
4"patient records", of which NTr(- 5000) were used for
training the PM (items above the heavy line in Table 1)
and NTs(- 1000) were used to test performance (items
below the line).
Table 1. Record format
Item Initial State Treatment Followup
(random) (random) Symptoms
(computed)
yg d ,d2 S,
a .aa a (dl ada)
NTr yNTr ,gNTr,sNTr (dNTr,d Tr) NTrI 1g5(d2) Sf
P y,gfl,sp (dj,dg) SP
NTs yNTs ,gNTs ,5NTs (di Ts,d2Ts) NTs
METHODS
The PM is a feed-forward network with 3 inputs (one
initial symptom value and two dosage values), 6 hidden
units, and a single output unit (followup symptom). It is
trained using items from the training set to predict the
followup symptom values in the presence of noise, and
subsequently tested. The backpropagation training
technique is used for the PM, with the Sf values as the
teacher signal (targets). In the backpropagation procedure,
the PM weights are iteratively modified by gradient
descent to minimize the objective function
NTr 2
ya (SS irps ,dla ,d2 ) [2]
a
where rpM is the output of the PM.
The test data is used to assess the generalization
performance of the PM; that is, the performance is
measured by the same objective function as measured over
the test set.
The TN is a feed-forward network with one input (the
initial symptom value), 6 hidden units, and two output
units (doses). After training the PM, the TN is trained
using a modified version of the backpropagation procedure
to optimize the output of the PM according to the objective
function
[3]
.j(s * -rpm T7 sa )
a
where s * is the desired symptom value, and rTN
is the output of the TN (dosage values).
In training the TN, it is important to observe that the PM
weights are held fixed. Note that if the PM weights were
allowed to change, the network could produce optimal
responses by simply ignoring the input and adjust the
output biases such that the predicted symptom was
optimal. By fixing the PM weights the TN is forced to
compute dosage values that optimize the symptoms.
RESULTS
The performances of both the PM and TN are graphically
displayed in Figures 2-6. Both networks performed well in
terms of their average responses (as shown by linear fits)
in response-target plots for each network.
The Patient Model
As illustrated in Figure 2, this network leams the task quite
well. The target value is plotted against the target value
from the data set for each item in the test set. Ideally, the
points should lie on the line x=y. The regression line
shows that the expected value of the output given a patient
state is very close to the ideal line.
The target function computed by the network is illustrated
for the space of possible doses in Figure 3, given an input
corresponding to a 25-year-old female. The solid curves
are contours of the target function, with the optimal value
(*) at the center. The dashed curves are contour lines for
the function computed by the PM. Notice that the contours
are close to each other near the optimum. However, far
from the minimum point, the PM contours deviate from
the target function contours, and even exhibit local
minima. Because of this, the TN is likely to converge to
the wrong minimum if the initial weights are not carefully
chosen. In every case we analyzed, the local minima ware
more distant from the origin than the "correct" minimum.
Therefore, as long as the initial weights are sufficiently
small, the network converges to the right value.
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Figure 2. Target values are plotted vs. outputs Figure 4. The performance of the TN is assessed by
computed by the PM after training for each item in plotting Output I from the TN vs the ideal value
the test set. The ideal line (dashed line) is plotted (age/100) for the test items. As in Figure 3, the best
together with the best linear fit (solid). linear fit (solid) is plotted with the ideal line
(dashed).
Figure 3. Contours for the noiseless function (Eq.
1, with n=O) is plotted as a function of the two
dosages (solid curves) for a 25-year-old female. The
asterisk shows the minimum of the fuction (optimal
doses) Contours for the function computed by the
PM are superimposed (dashed curves). The +
indicates the dose values to which the TN
converges.
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Figure 5. The performance of the TN is further
assessed by plotting Output 2 from the TN vs the
ideal value (0.3 for females, and 0.7 for males) for
the test items.
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Figure 6. The performance of the TN is further
assessed by plotting values for Dose 1 and Dose 2
computed by the TN (+) (as in Figure 3, but without
the contours) for six age-gender combinations. The
optimal doses (*) appear for comparison.
The Treatment Network
The TN is trained to find values for the treatment that
optimize the symptom, by backpropagating deviations
between the PM output and the optimal values. If the
optimum doses for the PM network closely approximate
the optimum doses for the final symptom function (Eq. 1),
then the TN will compute doses that are close to the ideal.
The doses prescribed by the TN are plotted against the
ideal doses for each item in the test set (Figures 4 and 5),
showing a close correspondence. The recommended doses
for a 30-year-old female woman are marked on the contour
map of the final symptom function (Figure 3) with the '+'
symbol. The TN performs a gradient descent computation
of the optimal doses; here, the minimum of the PM
function. The optimal points for the ideal function (*) and
the doses prescribed by the TN are shown in Figure 6 for 6
types of patients: males and females of ages 25, 45, and
65. The proximity of the TN output to the ideal dosage
values is a measure of the performance of the entire system
(PM and TN).
DISCUSSION
This study provides a "proof of concept" for the distal
leaming approach as a method for treatment optimization.
In principle, the system can be extended to account for
more complex interactions between treatments, and for
multiple symptoms. For example, side effects of
medication could be treated as other symptoms that need to
be optimized. The relative importance of primary
symptomatic measures (tumor size) vs. secondary
symptoms (side effects like nausea) can be adjusted by
weighting the terms in the objective functions (Eq. 2 and
3).
Previous studies of dose optimization algorithms have
been primarily focused on finding optimal angles and
intensities for radiation therapy against cancer (for
example, Brahme, 2000; Wu and Zhu, 2001). Generally,
these have been based on a biological model of the disease.
The technique put forward in this paper builds a purely
statistical model, which may be less appealing to patients
and physicians. On the other hand, this approach to
treatment optimization may prove itself a useful tool for
physicians to consult when deciding on dose strengths.
This approach may prove valuable as a technique for
providing patients with customized combinations of
medications (so-called "cocktails") for treating any of
several ailments, including asthma, ADHD, AIDS, various
cancers, diabetes, and schizophrenia.
Of course, the ultimate test of this framework would be
real data in which different dose combinations have been
administered to patients. Both the symptoms and the
treatments must be quantitative, and there is a need for at
least one followup data point for each patient. Ideally, a
clinical trial could be designed for the acquisition of the
data.
The performance of the PM is enhanced by a uniform
exploration of the dosage space. This would raise ethical
issues if human subjects were used, since some of the
medication levels and combinations may be dangerous.
Thus, initial experiments with this technique may be best
done on lower animals.
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